Paul Goldberg's novel, The Yid, was a finalist in the Goldberg Prize debut fiction category in the 2016 National Jewish Book Awards. The Yid is a dark comedy set in Moscow in 1953.
The wide-ranging public health initiative will cease to exist on Jan. 20—eight days short of a year after it was created—when the keys to the White House are handed over to Donald Trump.
With a simplified tech transfer agreement, six industry partners and 15 compounds (but no dedicated research funds), NCI challenges investigators to think creatively.
The Bonnie J. Addario Lung Cancer Foundation and the International Association for the Study of Lung Cancer announced the second annual joint fellowship award to support research on the early detection of lung cancer.
The American Association for Cancer Research announced the first public release of cancer genomic data aggregated through its initiative known as AACR Project Genomics Evidence Neoplasia Information Exchange (GENIE).
Strata Oncology today announced launch of the Strata Trial, a nationwide observational study providing no-cost tumor sequencing and clinical trial matching for 100,000 advanced cancer patients, to study the impact of tumor sequencing on clinical trial enrollment.
FoundationFocus CDxBRCA received FDA approval for use as a companion diagnostic to aid in identifying women with ovarian cancer.
Ionis Pharmaceuticals Inc. announced that it has earned $28 million from AstraZeneca following AstraZeneca's completion of IND-supporting studies and license of IONIS-KRAS-2.5, or AZD4785. IONIS-KRAS-2.5x is a Generation 2.5 antisense drug discovered by Ionis designed to directly target KRAS, one of the most frequently mutated genes in cancer.
MaxCyte Inc. and Washington University in St. Louis announced a collaboration to develop unique immunotherapy drug candidates based on MaxCyte's proprietary cell engineering platform technology, CARMA.
